Pathstone Family Office’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$509K Buy
7,241
+1,642
+29% +$123K ﹤0.01% 1024
2023
Q2
$452K Buy
5,599
+204
+4% +$14.7K 0.01% 795
2023
Q1
$390K Sell
5,395
-10,563
-66% -$823K 0.01% 793
2022
Q4
$1.12M Buy
15,958
+2,188
+16% +$180K 0.01% 747
2022
Q3
$1.08M Buy
+13,770
New +$1.1M 0.01% 694
2022
Q2
Sell
-2,298
Closed -$301K 1050
2022
Q1
$301K Buy
+2,298
New +$133K 0.01% 750
2021
Q4
Sell
-3,275
Closed -$208K 899
2021
Q3
$208K Buy
+3,275
New +$207K 0.01% 806
2019
Q2
Sell
-99
Closed -$3K 628
2019
Q1
$3K Buy
+99
New +$2.8K ﹤0.01% 668
2014
Q4
Sell
-44
Closed -$2K 110
2014
Q3
$2K Buy
+44
New +$2.15K 0.01% 285

Other funds holding ACHC

Pathstone Family Office's ACHC Position: Q3 2023 in Review

Pathstone Family Office increased its Acadia Healthcare (ACHC) stake by 29% in Q3 2023, buying an estimated $123K and bringing the position to 7,241 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

Pathstone Family Office first reported a position in ACHC in Q3 2014 and has held it in 9 quarters since. The position peaked at $1.12M in Q4 2022. 293 funds tracked by Wall St. Rank hold ACHC as of Q3 2023.

  • Pathstone Family Office held 7,241 shares of Acadia Healthcare worth $509K as of Q3 2023.
  • Pathstone Family Office bought 1,642 Acadia Healthcare shares in Q3 2023, an estimated $123K.
  • Acadia Healthcare made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1024 holding.
  • Pathstone Family Office first reported a position in Acadia Healthcare in Q3 2014 and has held it in 9 quarters since.
  • Pathstone Family Office's Acadia Healthcare position peaked at $1.12M in Q4 2022.
  • 293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.